A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising ...

KAIST researchers have developed a way to reprogram immune cells already inside tumors into cancer-killing machines. A drug ...

ProKidney Corp., a clinical-stage biotechnology company based in North Carolina, is developing a first-in-class cell therapy ...

For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important ...

Cold Spring Harbor Laboratory researchers reveal a groundbreaking approach using CAR T-cell therapy to rejuvenate aging ...

University of Utah researchers at the Pulst-Scoles Laboratory have discovered that reducing levels of the STAUFEN-1 protein ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...

With around one million people living with Parkinson’s disease in the U.S. — and 90,000 getting new diagnoses each year — the race is on for a cure. Researchers at Memorial Sloan Kettering Cancer ...

Researchers have unlocked a way to grow the immune system’s “conductors” from stem cells, bringing ready-made cancer-fighting therapies a big step closer. For the first time, scientists at the Univers ...

A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...

Researchers have discovered a way to help aging intestines heal themselves using CAR T-cell therapy, targeting senescent ...

The soft opening represents a significant milestone in RMTG's international expansion strategy, with plans to establish specialized infrastructure designed for the controlled manufacture, preservation ...